Drug Patent Expirations in October 2011
Drug Patent Expirations in October 2011
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| ZOLINZA | Merck | vorinostat | 6,087,367 | Oct 4, 2011 |
| ZORBTIVE | Emd Serono | somatropin recombinant | 5,288,703 | Oct 7, 2011 |
| NUTRESTORE | Emmaus Medcl | glutamine | 5,288,703 | Oct 7, 2011 |
| ATACAND | Astrazeneca | candesartan cilexetil | 7,538,133*PED | Oct 18, 2011 |
| ATACAND HCT | Astrazeneca | candesartan cilexetil; hydrochlorothiazide | 7,538,133*PED | Oct 18, 2011 |
| ATACAND | Astrazeneca | candesartan cilexetil | 5,705,517*PED | Oct 18, 2011 |
| ATACAND HCT | Astrazeneca | candesartan cilexetil; hydrochlorothiazide | 5,705,517*PED | Oct 18, 2011 |
| ELIGARD | Tolmar Therap | leuprolide acetate | 5,324,519 | Oct 20, 2011 |
| SYMBYAX | Lilly | fluoxetine hydrochloride; olanzapine | 5,229,382*PED | Oct 23, 2011 |
| ZYPREXA RELPREVV | Eli Lilly Co | olanzapine pamoate | 5,229,382*PED | Oct 23, 2011 |
| ZYPREXA | Lilly | olanzapine | 5,627,178*PED | Oct 23, 2011 |
| ZYPREXA | Lilly | olanzapine | 5,817,656*PED | Oct 23, 2011 |
| ZYPREXA | Lilly | olanzapine | 5,817,657*PED | Oct 23, 2011 |
| ZYPREXA | Lilly | olanzapine | 5,817,655*PED | Oct 23, 2011 |
| ZYPREXA | Lilly | olanzapine | 5,229,382*PED | Oct 23, 2011 |
| ZYPREXA ZYDIS | Lilly | olanzapine | 5,229,382*PED | Oct 23, 2011 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.
Courtesy of DrugPatentWatch.com


















Leave a Reply
Want to join the discussion?Feel free to contribute!